Search

Search results for

We found 2 results for you
  1. NDM-1, novel TEM-205, novel TEM-213 and other extended-spectrum β-lactamases co-expressed in isolates from cystic fibrosis patients from South Africa

    NDM-1, novel TEM-205, novel TEM-213 and other extended-spectrum β-lactamases co-expressed in isolates from cystic fibrosis patients from South Africa

    Item type: Journal Article • Journal: Southern African Journal of Infectious Diseases • Authors: Nonhlanhla Mhlongo --- Antimicrobial Research Unit, South Africa Sabiha Essack --- Antimicrobial Research Unit, South Africa Usha Govinden --- Antimicrobial Research Unit, South Africa
    Background: β-lactamase-mediated resistance was investigated in isolates from cystic fibrosis (CF) patients attending clinics in the public and private health sectors in Durban, South Africa.
  2. COLISTIN: adult and paediatric guideline for South Africa, 2016

    COLISTIN: adult and paediatric guideline for South Africa, 2016

    Item type: Journal Article • Journal: Southern African Journal of Infectious Diseases • Authors: Quinten Labuschagne --- South African Society of Clinical Pharmacy (SASOCP), South Africa Natalie Schellack --- South African Society of Clinical Pharmacy (SASOCP), South Africa Andries Gous --- South African Society of Clinical Pharmacy (SASOCP), South Africa Elmien Bronkhorst --- South African Society of Clinical Pharmacy (SASOCP), South Africa Gustav Schellack --- South African Society of Clinical Pharmacy (SASOCP), South Africa Lindie van Tonder --- South African Society of Clinical Pharmacy (SASOCP), South Africa Archele Truter --- South African Society of Clinical Pharmacy (SASOCP), South Africa Caroline Smith --- South African Society of Clinical Pharmacy (SASOCP), South Africa Ruth Lancaster --- South African Society of Clinical Pharmacy (SASOCP), South Africa Sonya Kolman --- South African Society of Clinical Pharmacy (SASOCP), South Africa
    This document was created to serve as a guideline for colistin prescribing in South Africa. Antimicrobial resistance is threatening the effective prevention and treatment of a wide variety of infections, especially those that are caused by multi-drug-resistant (MDR) gram-negative bacteria...